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ABSTRACT
The essential metabolic enzyme CTP synthase (CTPsyn) can be
compartmentalised to form an evolutionarily-conserved intracellular
structure termed the cytoophidium.Recently, it has been demonstrated
that the enzymatic activity of CTPsyn is attenuated by incorporation
into cytoophidia in bacteria and yeast cells. Here we demonstrate that
CTPsyn is regulated in a similar manner in Drosophila tissues in vivo.
We show that cytoophidium formation occurs during nutrient
deprivation in cultured cells, as well as in quiescent and starved
neuroblasts of the Drosophila larval central nervous system. We also
show that cytoophidia formation is reversible during neurogenesis,
indicating that filament formation regulates pyrimidine synthesis in a
normal developmental context. Furthermore, our global metabolic
profiling demonstrates that CTPsyn overexpression does not
significantly alter CTPsyn-related enzymatic activity, suggesting that
cytoophidium formation facilitates metabolic stabilisation. In addition,
we show that overexpression of CTPsyn only results in moderate
increase of CTP pool in human stable cell lines. Together, our study
provides experimental evidence, and a mathematical model, for the
hypothesis that inactive CTPsyn is incorporated into cytoophidia.
KEY WORDS: CTP synthase, cytoophidium, intracellular
compartmentation, CTP, Drosophila, neurogenesis
INTRODUCTION
In recent years it has become apparent from protein localisation
screens that an unprecedented number of metabolic enzymes are
incorporated into novel cytoplasmic bodies (Narayanaswamy et al.,
2009; Werner et al., 2009). The extent to which these aggregates
represent biologically meaningful structures remains unclear;
however there are well characterised examples in which the
assembly of higher-order structures regulates flux through specific
metabolic pathways. For example, it has been observed that six of
the key enzymes involved in the de novo synthesis of purine
nucleotides reversibly colocalise to discrete cytoplasmic bodies
(purinosomes) in response to depletion of purine concentrations
(An et al., 2008). It is thought that this aggregation occurs to
facilitate substrate channelling between enzymes in the same
pathway, although recent evidence has questioned whether these
bodies are physiologically relevant (Zhao et al., 2014).
A distinct subset of cytoplasmic bodies has been identified in
which enzymes are incorporated into filamentous structures. One of
the earliest enzymes to be identified as subject to regulation by the
assembly of monomers into higher-order structures is acetyl-CoA
carboxylase (ACC). Purified ACC from animal tissues has been
shown by electron microscopy to reversibly form filamentous
structures upon incubation with its allosteric activator, citrate
(Kleinschmidt et al., 1969). Conversely, incubation with malonyl
CoA or Mg2+ ions, both inhibitors of ACC, caused rapid
depolymerisation of citrate-induced filaments, indicating that
polymerisation of ACC is required to upregulate enzymatic
activity (Beaty and Lane, 1983a; Beaty and Lane, 1983b). One of
the best studied enzyme filaments so far is the essential de novo
pyrimidine biosynthesis enzyme, CTP synthase (CTPsyn). CTPsyn-
containing structures have been termed cytoophidia due to their
apparent snake-like morphology (from the Greek cyto, meaning
cell; and ophidia, meaning serpents) (Liu, 2010). The filament
forming properties of CTPsyn have been shown to be highly
conserved having been demonstrated in bacteria (Ingerson-Mahar et
al., 2010), yeast (Noree et al., 2010), Drosophila (Liu, 2010) and
human cells (Carcamo et al., 2011; Chen et al., 2011). The
conservation of this feature throughout evolution suggests that the
ability of CTPsyn to assemble into filamentous structures confers an
important biological function (for a review, see Liu, 2011).
The enzymatic activity of CTPsyn is regulated by all four
nucleotides, through substrate concentration/energy generation
(UTP, ATP) and allosteric interactions (CTP, GTP) (Levitzki and
Koshland, 1971; Levitzki et al., 1971; Lieberman, 1956; Long and
Pardee, 1967). ATP, UTP and CTP all promote assembly into the
tetramer form of the enzyme, and have been shown to increase
catalytic activity, whilst GTP acts as a positive allosteric activator
of the glutaminase activity of the enzyme, although this has been
shown to be non-essential in vitro (Aronow and Ullman, 1987;
Endrizzi et al., 2004; Goto et al., 2004; Pappas et al., 1998;
Robertson, 1995). Treatment of S. cerevisiae with CTP, an inhibitor
of CTPsyn activity, was shown to increase filament formation
(Noree et al., 2010). The compartmentalisation of CTPsyn has been
reported to be influenced by a variety of different extrinsic factors.
Treatment of S. cerevisiae with the non-specific kinase inhibitor
staurosporine resulted in an increased abundance of cytoophidia,
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leading to the suggestion that cytoophidium formation may be
dependent on phosphorylation of CTPsyn itself or of a critical
regulator (Noree et al., 2010). These data must be interpreted with
caution however, due to the broad effects of staurosporine which
are known to cause toxicity (Tamaoki et al., 1986).
Here we report that CTPsyn is compartmentalised in response
to nutrient stress in cultured Drosophila cells. Furthermore we
show that this effect is also apparent in Drosophila tissues in vivo.
We also show that dispersal of CTPsyn occurs in larval
neuroblasts in vivo upon exiting quiescence, indicating that the
formation of cytoophidia occurs just prior to neuronal stem
cell activation. In addition, cytoophidia formation occurs in
neuroblasts when young larvae are starved – a process that
stalls larval growth and cell proliferation (Tennessen and
Thummel, 2011). We then aimed to further understand the
metabolic effects of CTPsyn compartmentalisation. To this end,
we performed metabolomic profiling of 308 metabolites on adult
flies and found that overexpressing CTPsyn does not change
CTPsyn-related enzymatic activity, suggesting that cytoophidium
formation aids metabolic stabilisation. Furthermore, we show that
overexpression of CTPsyn only results in moderate increase of
CTP pools in human stable cell lines. Finally, we report that point
mutations at critical residues in the tetramer and dimer interfaces
of CTPsyn have an effect on cytoophidia formation indicating
that CTPsyn multimers may be incorporated into cytoophidia.
Based on our experimental data, we propose a simple
mathematical model to explain the dynamics of cytoophidium
formation, which accurately predicts CTPsyn concentration
dependent changes of intracellular CTP nucleotides.
MATERIALS AND METHODS
Cell culture
Drosophila S2R+ cell lines obtained from the Drosophila Genome Resource
Centre (DGRC) were grown at 25 C˚ in Schneider’s medium with 10% heat-
inactivated fetal bovine serum (FBS) following standard protocols. Human
293T cells were maintained in DMEM (Invitrogen, 11960) supplemented
with 10% FBS (Bioindustry), glutamine 2 mM (Invitrogen, 25030) and 1%
Penicillin–Streptomycin solution (Gibco, 15140). Cells were kept in a 37 C˚
incubator with 5% CO2. For western blot assays, transfected 293T cells were
selected with puromycin 10 mg/ml (InvivoGen, ant-pr-5b).
Transfection of Drosophila and human cells
Drosophila S2R+ cells were diluted to 16106 cells/ml and left to settle on
coverslips in a 24 well plate overnight. If cells were intended for
immunostaining, autoclaved coverslips were added to wells for cells to
adhere to. 1 mg of DNA with 3 ml of FuGENE HD was added to 50 ml of
water and mixed by flicking. DNA-FuGENE mixture was incubated at
room temperature for 20 minutes. The DNA-FuGENE solution was
dropped evenly onto the S2R+ cells and left to transfect for 24 hours before
preparing samples for immunofluorescence. Control wells containing no
plasmid DNA or empty vector were included for each transfection
experiment. To generate stable cell lines, 4.5 mg expression constructs
were co-transfected with 0.5 mg pCopuro puromycin resistance plasmid
(Addgene). Cell culture medium was supplemented with 2 mg/ml
puromycin after 48 hours to select against non-transfected cells. Cultures
were maintained in 2 ml/ml puromycin thereafter.
For transfection of human 293T cells, full length mouse CTP
synthetase 1 cDNA sequence was cloned into pLVX-EF1alpha-AcGFP-
N1 vector (Clontech, 631983). CTPsyn1-GFP and GFP vector were
introduced into cells with jetPEI (polyplus) transfection reagents
following manufacturer’s protocol.
Immunofluorescence and microscopy
All cultured cells were fixed in 4% paraformaldehyde in PBS for
10 minutes and washed with PBT (16 PBS + 0.5% horse serum + 0.3%
Triton X-100) before imaging. Drosophila larval tissues were obtained
from age-matched animals raised on apple juice agar plates supplemented
with wet yeast. All tissues were dissected into Grace’s Insect Medium, fixed
in 4% paraformaldehyde in PBS for 10 minutes and washed with PBT.
Samples were incubated in primary and secondary antibodies consecutively
overnight with intervening washes in PBT. Primary antibodies used were
rabbit anti-CTPsyn (Santa Cruz 134457), mouse anti-miranda (gift from
Fumio Matsuzaki). Rabbit anti-CTPS antibody (1:500, GeneTex,
GTX105265) was used for staining in human cells. Secondary antibodies
used were: donkey anti-rabbit Cy5 (Jackson 711-175-152), donkey anti-
goat alexa 488 (molecular probes A11055), donkey anti-goat 549 (Jackson
711-585-152). Hoescht 33342 (1 mg/ml) was used to label DNA. All
samples were imaged using a Zeiss LSM 510 META confocal microscope.
Image processing and analysis was conducted using ImageJ.
Generation of CTPsyn expression constructs and mutants
A metallothionein (MT) promoter sequence was amplified from pMT/V5-
HisA using primers containing adaptors with BglII and EcoRV digestion
sites with Expand high fidelity DNA polymerase. The amplified promoter
sequence and the pAVW destination vectors from the Drosophila gateway
vector collection (obtained from the Drosophila Genomics Resource
Centre, Bloomington, IN) were digested using BglII and EcoRV (NEB)
and ligated together with the amplified pMT promoter to generate the
pMT-VW expression vector. CTPsyn was cloned into pMT-VW using the
Gateway recombination system (Invitrogen). Single base substitutions
were made in the pMT-VW-CTPsyn expression vector (decribed above)
using a quickchange PCR protocol. PCR primers were designed to include
nucleotide substitutions of interest. PCR was performed on the pMT-VW-
CTPsyn expression vector using Phusion high fidelity polymerase (NEB).
Following amplification, template DNA was digested using Dpn1. Plasmid
DNA was purified using a MinElute low volume PCR purification kit
(Qiagen) and transformed into E. coli DH5a cells.
Drosophila genetics
To overexpress CTPsyn in various tissues, w ; pUASp-CTPsyn/Cyo flies
(as described by Azzam and Liu, 2013) were crossed to the Act5c-Gal4
driver (Bloomington Drosophila stock centre) for ubiquitous expression.
For neuroblast overexpression Pros-GAL4 was obtained from the
putative-enhancer collection (Bloomington Drosophila Stock Centre
[BDSC] at Indiana University, USA). Flies expressing UAS driven
shRNA targeting AKT1 (P(KK100495)VIE-260B; Vienna Drosophila
RNAi Center, Vienna) were crossed to flies with a GAL4 driver expressed
in neuroblasts (Insu-GAL4, gift from Ju¨rgen Knoblich) (AKT1 RNAi line
previously characterised by Lee et al., 2013).
Analysis of Drosophila neuroblasts and imaginal tissues
w1118 larval CNS and imaginal discs were dissected for all wild-type
experiments. Well-fed larvae were reared on apple juice plates with
standard medium comprising of 80 g/l maize, 18 g/l dried yeast, 10 g/l
soya flour 80 g/l malt extract, 40 g/l molasses, 8 g/l agar, 6.6 ml acid
mix (comprising 50% propionic acid and 3.2% phosphoric acid)/l
throughout larval life. For larvae on a restricted diet, larvae were
removed at 5 hours and 24 hours for CNS and imaginal disc studies
respectively, and placed on apple juice plates. CNS were imaged at
24 hours after larvae were removed from food (L2 stage) and imaginal
discs were imaged 52 hours after removal from food (Stage L3). For
larval starvation and re-feeding assays 1st instar larvae were starved for 1
day, then transferred to food and the number of neuroblasts containing
cytoophidia were scored after 0, 1 and 5 hours. CNS and imaginal tissues
were dissected, and fixed for 10 min in 4% paraformaldehyde.
Immunofluorescence was performed using rabbit anti-CTP synthase
y88 (sc-134457, 1:1000 Santa Cruz BioTech), rabbit anti-Miranda
(1:200, gift from C. Doe,), guinea pig anti-Dpn (1:10,000, gift from J.
B. Skeath), as previously described (Grice and Liu, 2011).
Western blotting
Cell lysates were run on a 12% polyacrylamide gel and transferred to a
PVDF membrane (GE Healthcare). To prevent non-specific binding of
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antibody, membrane was incubated in blocking buffer (5% milk in PBS)
for 1 hour in room temperature. After blocking, the membrane was
incubated in primary antibodies overnight at 4 C˚. Primary antibodies:
rabbit anti-CTPS IgG antibody (GeneTex, GTX105265) and mouse anti-
aTubulin IgG (Sigma, T5168) were diluted in blocking buffer in 1:4000
and 1:10,000 dilution, respectively. For Drosophila western blots
(supplementary material Fig. S3, Fig. S4B) rabbit anti-Histone H3
antibody (abcam ab1791) was used for the loading control (1:10,000).
Following 3 washes with 1% Tween-20 in PBS, the membrane was
incubated in secondary antibodies at room temperature for 1 hour.
Secondary antibodies: HRP-conjugated anti-rabbit IgG (GeneTex,
GTX77137) and anti-mouse IgG (PerkinElmer Life Sciences Inc.,
NEF822), were diluted in blocking buffer in 1:2000 and 1:20,000
dilution, respectively. The bound antibodies were detected with
LuminataTM Forte Western HRP Substrate (Millipore, WBLUF0500)
and X-ray film. Relative protein abundances were measured using
imageJ.
Quantification of intracellular nucleotides
76106 cells were washed with 16phosphate buffer (pH 7.4) and lysed in
80% methanol. After centrifugation at 12,000 r.p.m. for 10 min at 4 C˚,
supernatants were dried and kept at 280 C˚ before injection. The pellet
was resuspended in 200 ml water. 5 ml aliquots were injected onto a
separation column (ACQUITY UPLC BEH C18, 1.7 mm, 2.16100 mm
reversed-phase column, Waters) with a flow rate of 0.5 ml min21 and
analysed with an Acquity Ultra Performance Liquid Chromatography
(UPLC Waters) interfaced with PDA photodiode Array (Waters). Mobile
phase A was 50 mM TEAA with 4 mM EDTA, pH 7.0 and mobile phase
B, 100% acetonitrile. A programmed mobile phase-gradient was used
during a 10-min run: 0 min, 0.1% B; 6.8 min, 2% B; 6.9 min, 0.1% B;
10 min, 0.1% B. The concentration of the four nucleotides ATP, UTP,
CTP and GTP was quantified at 270 nm absorbance. Concentrations were
determined by using calibration curves of the four nucleotides. The
linearity gave a correlation coefficient of the linear regression curves
greater than 0.99 for the four nucleotides. Peak areas were integrated, and
the amounts calculated were as follows: ATP, 4.7 min; UTP, 2.7 min;
CTP, 2.1 min, and GTP, 1.5 min.
Metabolomic profiling
Young adult female flies are fed with wet yeast for 2 days before the
collection. The following three groups of flies were collected: 1) Control
group – y,w flies fed with normal food; 2) Inhibition group – y,w flies fed
with food containing 1 mg/ml DON to inhibit CTPsyn activity; 3)
Overexpression group – globally overexpressing CTPsyn using an actin-
GAL4 driver. These flies were subdivided into 30 subgroups with 100
flies in each subgroups. In total 3000 flies were collected for the
metabolic profiling. Whole flies were frozen in liquid nitrogen and
shipped to Metabolon, Inc (Durham, North Carolina, USA) for
metabolomic profiling.
RESULTS
Cytoophidium assembly occurs in response to nutrient stress
It was previously shown that S. cerevisiae cells grown in media
lacking glucose exhibited greater numbers of CTPsyn filaments
(Noree et al., 2010). This effect could be reversed by addition of
glucose. To see if the response to nutrient stress is evolutionarily
conserved, we removed cell culture medium from Drosophila
S2R+ cells in logarithmic growth and incubated with PBS. Cells
were examined by immunofluorescence at various time points to
determine the effect of nutrient stress on cytoophidium assembly.
A significant increase in number of cytoophidia was seen after
one hour, the shortest interval measured. Numbers of cells with
visible cytoophidium formation reached a maximum of around
20%, after 4 hours in PBS (Fig. 1A). The observed response of
cytoophidia to nutrient stress could be reversed by the re-addition
of whole media (Fig. 1B). It remained unclear whether the
increased cytoophidium formation displayed by nutrient restricted
cells was a consequence of cell cycle arrest. We performed Edu
staining to label S-phase cells in nutrient restricted cells to give
an indication of the number of cells exiting the cell cycle. No
significant change in Edu staining was seen following 5 hours of
nutrient restriction, indicating that cell cycle arrest is not
necessary for cytoophidium formation in cells undergoing
nutrient restriction (Fig. 1C).
To investigate whether nutrient induced change in CTPsyn
localisation was conserved in animal tissues in vivo, we raised
larvae on food for 24 hours, transferred them onto minimal food
for 52 hours, and then dissected. The time analysed corresponded
to the third instar stage. Imaginal discs, including wing, leg, and
haltere, display diffuse CTPsyn staining and exhibited no visible
cytoophidia in well fed larvae (Fig. 1D). In nutrient restricted
larvae, cytoophidia were abundant in the imaginal discs (eye,
wing, leg and haltere) of third instar larvae, which were also
reduced in size (Fig. 1D, showing imaginal discs from a nutrient
restricted larva). In summary, CTPsyn localisation changes as
part of an adaptive metabolic response to inactivate cytoplasmic
CTPsyn during nutritional stress in vivo.
Redistribution of CTPsyn occurs during Drosophila
neurogenesis
Having seen that cytoophidium formation was responsive to
nutrient stress in vivo we asked whether cytoophidium formation
may be required during normal developmental processes. The
post embryonic neuroblasts of the Drosophila CNS have
previously been shown to exhibit high levels of cytoplasmic
(i.e. non-filamentous) CTPsyn (Chen et al., 2011). The majority
of these neuroblasts remain in a quiescent state during the early
1st instar larval stage (Fig. 2A). When the larvae have the
required access to food, neuroblasts exit quiescence and re-enter
the cell cycle during late 1st (L1) and early 2nd instar (L2) stages
(Chell and Brand, 2010; Sousa-Nunes et al., 2011; Truman and
Bate, 1988). As the demand for nucleotides is upregulated in
proliferating cells, we hypothesised that there may be a
concomitant switch in cytoophidium assembly/disassembly. We
dissected 1st and 2nd instar larvae and investigated CTPsyn
distribution by immunofluorescence. In well fed larvae, CTPsyn
can be observed in filaments in the early 3rd instar thoracic
ganglion, however these filaments disappear as larvae develop
through L2 and L3 stages (Fig. 2A,B). The cytoophidia appear on
the ventral surface in cells corresponding to the regions where the
quiescent neuroblasts reside (Fig. 2C). As neuroblasts exit
quiescence they enlarge and begin to divide. Following this
process CTPsyn filaments disappear, and CTPsyn is localised in
the cytoplasm in a diffuse pattern (Fig. 2D).
Nutritional restriction during neurogenesis leads to
cytoophidium formation
Neuroblasts continue to divide throughout larval life and CTPsyn
remains diffuse in the neuroblast cytoplasm throughout this
period (Chen et al., 2011). Nutritional stress during this period
has been shown to affect neuroblast division and cell cycle entry.
For example, when young larvae are starved before a critical
weight period is reached (during the L3 stage), developmental
progression and neurogenesis is halted (Tennessen and Thummel,
2011). To model nutritional stress, and to stall growth and
neurogenesis, we transferred newly hatched larvae from basic
food to apple juice plates, after 12 hours. We then reared the
larvae on apple juice plates for 24 hours plates before dissecting.
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In these starved larvae, cytoophidia can be found in the majority
of neuroblasts (Fig. 2E). We next looked to see how the re-
addition of food, and thus the re-initiation of neurogenesis, affects
the presence of cytoophidia (Fig. 3). 1st instar larvae were
starved for 1 day, and then transferred to food. The number of
neuroblasts containing cytoophidia was scored after 0, 1 and
5 hours (Fig. 3A). We found that re-feeding induced the
dissociation of the cytoophidia in neuroblasts, which had
accumulated during the starvation period (Fig. 3B,C). In
addition, 5 hours after the re-addition of the normal diet,
cytoophidia numbers were comparable with those seen in well
fed L2 larvae. Furthermore, strong cytoplasmic staining was seen
to reappear in the neuroblasts of these animals (Fig. 3C). These
data again suggest that CTPsyn localisation changes as part of an
adaptive metabolic response to inactivate cytoplasmic CTPsyn
during nutritional stress in neuroblasts.
To mimic nutritional stress, we also knocked-down the serine-
threonine kinase AKT1 in neuroblasts using Insc-GAL4, UAS-
AKT1-RNAi. During L1 and L2, normal food intake activates
insulin signalling and the PI3K/AKT pathway. This in turn
activates TOR, and represses the growth inhibitor Foxo, leading
to the initiation of neuroblast division and cell proliferation
(Fig. 4A) (Chell and Brand, 2010; Goberdhan and Wilson, 2003;
Sousa-Nunes et al., 2011). Insc-GAL4, UAS-AKT1-RNAi
neuroblasts have increased numbers of cytoophidia when
compared to controls (Fig. 4B–D), suggesting that inactivation
of the AKT1 pathway induces cytoophidia formation. The
prolonged presence of cytoophidia in the neuroblast however,
appears to have no detrimental effect. Overexpression of CTPsyn
in the neuroblasts (Pros-GAL4, UAS-CTPsyn-A) generates
extremely large cytoophidia, but this has no overt effect on
overall development (supplementary material Fig. S1). In
summary, cytoophidia are formed in neuroblasts that are
quiescent, or in neuroblasts from the CNS of starved and
developmentally stalled larvae. These results are consistent with
the hypothesis that CTPsyn in cytoophidia is inactive.
Either inhibition or overexpression of CTPsyn promotes
cytoophidium assembly
We have previously shown that in human cells that the proportion
of cells containing visible cytoophidia is low during logarithmic
growth under standard conditions, with around 5% of cells
displaying filaments (Chen et al., 2011). Filaments could be
induced to form when cells were treated with the glutamine
analogues 6-Diazo-5-oxo-L-norleucine (DON) and azaserine,
which both act as competitive inhibitors of CTPsyn.
Fig. 1. Cytoophidium assembly occurs in response to nutrient stress. (A) Mean number of cells containing visible cytoophidia increases in nutrient
restricted cells. Significantly more cytoophidia are seen in S2R+ cells in PBS after just one hour. Control cells are maintained in complete Drosophila Schneider’s
medium. At least 100 cells were counted from ten sites per well from at least three independent replicates. (B) Cells with increased numbers of cytoophidia
following nutrient restriction can be rescued by addition of whole media. Cells were examined two hours after re-introduction of whole media. (C) No significant
change in EdU marked cells is observed after 5 hours, indicating that cell cycle arrest is not necessary for cytoophidia formation in S2 cells. (D) Response to
nutrient restriction in imaginal disc tissue in vivo. Imaginal discs of L3 larvae display only diffuse cytoophidia when fed a normal diet. (E) In larvae raised on a
nutrient restricted diet, the imaginal discs are smaller and cytoophidia are highly prevalent. Scale bars: 10 mm. ***P,0.001, **P,0.01, *P,0.05.
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In order to investigate whether Drosophila cells displayed
similar properties to human cell lines, S2R+ cells were treated
with varying concentrations of DON. In untreated cells very low
endogenous numbers of cytoophidia (<3%) could be detected by
immunofluorescence, whilst significant increases were observed
in DON-treated cells as previously reported (supplementary
material Fig. S2A–C). Furthermore, the response of S2R+ cells to
DON was proportional to the concentration of drug applied as
observed in human cells in vitro.
We have reported that only one isoform of Drosophila CTPsyn
is able to form cytoophidia (Azzam and Liu, 2013). Ectopically
expressing the cytoophidium-forming isoform of CTPsyn can
induce cytoophidia in many tissues in Drosophila (Azzam and
Liu, 2013). To see whether expression of CTPsyn would also
Fig. 2. CTPsyn distribution in
Drosophila larval post embryonic
neuroblasts (pNbs). (A) A schematic of
the larval CNS showing the location of
the pNbs. The box represents the
section of the CNS represented in
panels C and D. The majority of larval
pNbs exit quiescence during the late L1
(1st instar) and early L2 (2nd instar)
stages. This is characterised by pNb
enlargement and the expression of
markers such as Miranda (Mir).
(B) Counts of pNbs containing
cytoophidia in L2 early, L2 late and L3
larvae early reared under different
feeding conditions (ND, normal diet; FR,
food removed). n.10 animals per
group. (C) CTPsyn localisation in early
and late L2 when on a normal diet (see
Materials and Methods). CTPsyn forms
cytoophidia in quiescent pNbs (Mir
negative). (D) As neuroblasts exit
quiescence (late L2, normal diet) and
begin to divide CTPsyn becomes
diffuse. (E) CTPsyn localisation in late
L2 when food is removed (late L2, food
removed) after 24 hrs. CTPsyn
aggregates into filaments when
nutritional stresses are present. These
images are representative of all 10
animals imaged. Scale bars: 10 mm.
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induce cytoophidium formation in cell culture, CTPsyn was cloned
into an expression vector under the control of a metallothionein
promoter with a venus (EYFP) fluorescent tag (referred to as
CTPsyn-YFP hereafter). This expression construct was transfected
into Drosophila S2R+ cells and stable lines established in order to
further investigate the formation of cytoophidia in vivo.
Fig. 4. AKT1 knockdown induces Cytoophida
formation. (A) When nutrients are available insulin-like
peptides (ILPs) bind the insulin receptor (InR), activating
the PI3K/AKT pathway. This in turn inhibits the growth
inhibitor Foxo and activates TOR, leading to growth and
division of cells, including neuroblasts. (B) AKT1 was
knocked down in neuroblasts using Insc-GAL4, UAS-
AKT1-RNAi to mimic nutritional stress. AKT1 knockdown
induces cytophidia formation. (C) Insc-GAL4 controls
displayed very few neuroblasts with cytophidia.
(D) Cytophidia in Insc-GAL4, UAS-AKT1-RNAi
neuroblasts. These images are representative of .6
animals imaged. Scale bars: 10 mm.
Fig. 3. Re-feeding starved larvae
promotes cytoophidia disassembly.
(A) 1st instar larvae were starved for 1
day. Larvae were then transferred to
food and the number of neuroblasts with
cytoophidia were scored after 1 and
5 hours. (B) Re-feeding induces the
dissociation of the cytoophidia in
neuroblasts that accumulated during
starvation. After 5 hours cytoophidia
numbers are comparable with those
seen in well fed L2 larvae.
(C) Representative pictures CNS from
larvae that have been re-fed for 0 hr,
1 hr and 5 hrs. These images are
representative of .6 animals imaged.
Scale bars: 10 mm.
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To determine whether expression of the CTPsyn-YFP
transgene had an adverse effect on cell survival, cells were
assayed for viability using a trypan blue dye exclusion assay.
Loss of cell viability has been reported at concentrations
exceeding 1 mM (Southon et al., 2004). Transgene expression
was induced using 1 mM CuSO4 to achieve robust expression
without affecting cell viability. No discernible difference in
viability was observed in cells in which transgene expression was
induced by CuSO4 for 8 hours, compared to uninduced or wild-
type S2R+ cells indicating that CTPsyn overexpression has no
adverse effect on the health of cell cultures (supplementary
material Fig. S2E). Cytoophidium forming properties of the
developed transgenic cell line were examined over time after
CuSO4 induction, by fixing cells in paraformaldehyde and
imaging at various timepoints. Cytoophidia were visible at very
low levels after 4 hours post induction in less than 5% of cells.
Cytoophidia were visible in 100% of cells after ten hours of
incubation with CuSO4 (supplementary material Fig. S2D). The
mean cytoophidia area increased with time. The average number
of filaments per cell increased very rapidly between four and five
hours, then decreased until eight hours, during which time the
mean filament size increased significantly due to fusion of
smaller cytoophidia into larger structures as previously reported
(Gou et al., 2014) (supplementary material Fig. S2F). Together,
these data indicate that cytoophidium formation is proportional to
CTPsyn concentration.
Fig. 5. Global metabolomic profiling indicates negligible changes in CTPsyn activity in vivo. (A) Principle component analysis shows that the samples of
wild-type (Wt), CTPsyn inhibition (In), and CTPsyn overexpression (Oe) groups are clearly segregated. Two principal components (PC1 and PC2) are plotted
and their proportions of variance are labeled. (B) The mean values of compounds in each state were normalized to (21,1) and clustered into nine patterns by
self-organizing mapping. The numbers of compounds in each pattern are showed on the top of the grids. The patterns that contain the most compounds
are indicated by (I, II, III, V). (C) The heat map shows metabolites in major patterns that have significantly differential levels in three groups. Seventy-two
metabolites in major patterns of (B) SOM (I, II, III, IV) were selected by one-way ANOVA with Bonferroni adjusted P,1025. (D) The levels of glutamine in three
groups are shown in the boxplot. Glutamine belongs to pattern I and is also colored in red in panel C.
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Analysis of CTPsyn overexpression on metabolic profiles
In previous studies, we have shown that overexpression of
CTPsyn or treatment with small molecule inhibitors is sufficient
to induce abundant cytoophidia formation in Drosophila tissues
in vivo (Azzam and Liu, 2013; Chen et al., 2011). In order to
investigate the effect of altered CTPsyn concentrations and
cytoophidia abundance on cellular physiology, we conducted
metabolomic profiling on flies either overexpressing CTPsyn,
treated with DON, or wild-type controls. We obtained global
metabolome profiles covering 308 metabolites in three groups of
Drosophila: flies with CTPsyn overexpression (Oe, as described
by Azzam and Liu, 2013), wild-type flies treated with CTPsyn
inhibitor DON (In), and wild-type flies with no treatment as a
control (Wt).
Principle component analysis of metabolome data showed that
the three groups are clearly distinct from each other in terms of
their global metabolite levels (Fig. 5A). We then used a self-
organizing map (SOM) to reveal the relative metabolite changes
Fig. 6. CTPsyn, cytoophidia and CTP production. (A) Cytoophidia are undetectable in wild-type and GFP vector transfected human 293T cells. (B) The
mCTPsyn1-GFP proteins were stably expressed by CTPsyn1 OE#1, CTPsyn1 OE#2 and CTPsyn1 OE#3 cell lines. Almost every cell contains one or more
cytoophidia. (C) Quantification of length of cytoophidia expressed by three independent cell lines. (D) Western blot of CTPsyn1 protein in wild-type, and
mCTPsyn1-GFP expressing 293T cell lines. (E) Quantification of the relative protein abundance of endogenous CTPsyn1 and exogenous mCTPsyn1-GFP in
CTPsyn1 OE#1, CTPsyn1 OE#2 and CTPsyn1 OE#3 cell lines. (F) The relative CTP concentration in cell lysates of wild-type, and three CTPsyn1
overexpression 293T cell lines. Overexpression of CTPsyn moderately increased intracellular CTP concentration in human cells. (G) The fitting of total CTPsyn
and CTP concentration using the non-linear relationship derived from our mathematical model (see text). The x axis is total CTPsyn and y axis is CTP
concentration. Data points represent experimentally measured values in wild type and CTPsyn overexpressing human 293T cells. (H) Proposed model of
cytoophidia assembly in response to nutrient or developmental conditions. Scale bars: 20 mm.
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among the three groups for all metabolites. As shown in Fig. 5B,
four major patterns emerge: low–low–high (I, upper left), high–
low–low (II, upper right), low–high–high (III, lower left), and
high–high–low (IV, lower right) in Oe, Wt, and In group
respectively. We found that the metabolites involved in amino
acid metabolism are enriched in pattern I (P50.005, Fisher’s
exact test), lysolipids are enriched in pattern II (P50.0008) and
dipeptides are enriched in pattern IV (P50.0001).
To ensure that these metabolites show statistically significant
differences among the three groups, we applied one-way ANOVA
to further select the metabolites (Bonferroni adjusted P,1025)
belonging to the four major patterns (Fig. 5C). For the metabolites
in patterns I and IV, the treatment of CTPsyn inhibition strongly
influenced their levels compared to the control while the mutants
with CTPsyn overexpression have no difference compared to the
control. Glutamine belongs to pattern I and shows increased level
in In compared to Wt and Oe (Fig. 5D). This can be explained by
the fact that the inhibition of glutaminase activity of CTPsyn may
lead to the accumulation of glutamine. The similar levels of
glutamine between Oe and Wt groups suggest that the glutaminase
activity of CTPsyn remains the same even after the overexpression
of CTPsyn. These two major patterns support the idea that the
CTPsyn sequestered in the cytoophidia filament has no CTPsyn-
related enzymatic activity. For the metabolites in patterns II and III,
the overexpression of CTPsyn strongly influenced their levels
compared to the control and the group with CTPsyn inhibition.
These groups of metabolites are unrelated to the canonical enzyme
function of CTPsyn as they show no difference with the control
after the inhibition of CTPsyn. These changes may be accounted
for by the presence of Gal4 in the Oe group. However, some
changes may be the result of metabolic functions of cytoophidia. In
conclusion, our analysis of metabolome data supports the
hypothesis that the formation of cytoophidia could sequester
CTPsyn enzyme activity.
Overexpression of CTPsyn only moderately increases CTP
pool in human cells
According to previous studies, manipulations of certain
conditions, such as glutamine deprivation or inhibition of GTP
synthesis with drugs, could stimulate cytoophidium formation in
some cells (Calise et al., 2014; Gou et al., 2014). To investigate
the function of the cytoophidium in mammalian cells, 293T cells
were transfected with a construct of mouse CTP synthase 1-GFP
fusion protein (mCTPsyn1-GFP) which is driven by the EF1a
promoter. Expression of mCTPS1 promoted assembly of
cytoophidia in 293T cells in normal culture condition
(Fig. 6A,B). Cytoophidia in mCTPS1-GFP expressing cells
were significantly longer than those in normal 293T cells with
or without DON treatment (Fig. 6B,C; supplementary material
Fig. S4), indicating that more CTPsyn proteins accumulated in
cytoophidium structure in cells expressing mCTPsyn1. We
generated three stable cell lines overexpressing mCTPsyn1-GFP
at approximately 6–8-fold higher than endogenous levels.
(Fig. 6D,E). However, the intracellular CTP concentration only
increased to 2-fold higher than that of wild-type cells indicating
that CTPsyn activity does not increase linearly with protein
concentration (Fig. 6F).
Mutations at the CTPsyn oligomer interfaces alter
cytoophidia assembly
End product inhibition of CTPsyn by CTP is critical for the
regulation of its enzymatic activity (Aronow and Ullman, 1987;
Endrizzi et al., 2005; Long and Pardee, 1967). Previous experiments
have shown that a mutation at the CTP binding site of CTPsyn in S.
cerevisiae inhibited end product inhibition by CTP (Ostrander et al.,
1998). Site-directed mutagenesis was used to construct a point
mutation at the equivalent conservedCTPsyn residue (CTPsynE160K)
in CTPsyn-YFP expression vector (supplementary material Fig. S2).
When CTPsynE160K was transfected into Drosophila S2R+ cells,
cytoophidium formation was seen to be completely disrupted,
although diffuse cytoplasmic YFP could be seen, along with
numerous punctate structures (supplementary material Fig. S5).
Similar results have previously been reported in S. cerevisiae
indicating that regulation of cytoophidium formation by end-product
inhibition is an evolutionarily conserved phenomenon (Noree et al.,
2010).
Allosteric binding of CTP has been shown previously to induce
CTPsyn tetramer formation (Long and Pardee, 1967). It has also
been demonstrated that treatment with the CTPsyn inhibitor, 6-
Diazo-5-oxo-L-norleucine (DON), reduced the amount of CTPsyn
tetramerisation in E. coli, which suggests that the tetramer form of
the enzyme may be excluded from cytoophidia (Robertson, 1995).
From these data it is unclear whether CTPsyn monomers, dimers or
tetramers are incorporated into cytoophidia. We therefore decided
to investigate the effect of mutations influencing residues at the
tetramer or dimer interface of CTPsyn on cytoophidium assembly
(supplementary material Fig. S4). We constructed point mutations
in CTPsyn-YFP at the tetramer interface (CTPsynG151E and
CTPsynR163H) and assayed for filament formation in S2R+ cells.
Both CTPsynG151E and CTPsynR163H resulted in significantly
longer cytoophidia when expression was induced in S2R+ cells
compared to wild type protein controls (supplementary material
Fig. S5). These data indicate that tetramer formation may not be
necessary for CTPsyn to form cytoophidia. To determine whether
CTPsyn dimer formation is necessary for cytoophidium formation
we constructed point mutations at the monomer–monomer
interface, predicted to disrupt dimer formation (CTPsynV114F and
CTPsynM156I). Both CTPsynV114F and CTPsynM156I resulted in
significantly shorter cytoophidia when expressed in S2R+ cells
(supplementary material Fig. S5). Cytoophidium formation was
not disrupted completely as in CTPsynE160K. It is unclear to us
whether this is due to incomplete disruption of dimer formation in
CTPsynV114F and CTPsynM156I. To determine whether changes
in cytoophidia formation were due to changes in CTPsyn
abundance, we performed western blots to detect the relative
amounts of expressed proteins for each mutant. Comparison of
relative CTPsyn abundances indicates that most of the mutant
proteins did not result in an apparent change in protein abundance.
However, CTPsynR163H and CTPsynE160K appeared to have
significantly lower protein levels. CTPsynR163H displayed longer
cytoophidia than wild type, despite lower protein abundance,
whereas CTPsynE160K displayed significantly less cytoophidia and
had clear morphological differences. Therefore, we conclude that
CTPsyn increase is not a significant confounding factor in the
interpretation of these phenotypes. Together these results imply
that CTPsyn dimers may be the multimer subunits of cytoophidia,
whilst tetramers may not necessarily be required for cytoophidium
assembly.
A simple mathematical model of cytophidium formation
Two types of cytoophidia have been described in Drosophila
germline cells, distinguished by their relative sizes; micro-
cytoophidia and macro-cytoophidia (Liu, 2010). More recently,
we have demonstrated that micro-cytoophidia can undergo
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multiple rounds of fusion to form macro-cytoophidia in
mammalian cells (Gou et al., 2014). Here we developed a
simple mathematical model to describe the incorporation of
CTPsyn into cytoophidia. First, we only consider the micro-
cytoophidia of size N polymerised sequentially at both ends from
CTPsyn n-mers (n52 for dimer and n54 for tetramer). The
kinetic constants of nucleation and de-nucleation of n-mers in the
filament are Kz and K{ respectively. Under biochemical
equilibrium, the numbers of filaments of length i, Di, satisfy:
K{Diz1~KzDiD1, 1ƒivN
This leads to the exponential distribution of Di: Di~D1r
i{1,
where r~
Kz
K{
D1.
Here n-mers are formed from CTPsyn monomers with kinetic
constants: Kinit and Kof f respectively. Therefore D1~
Kinit
Kof f
cn
where c is the number of CTPsyn monomers. The total amount of
CTPsyn is the sum of free CTPsyn monomers and those
sequestered in filaments:
CTotal~czn
XN
i~1
iDi~cz
nK{
Kz
F
c
ccrit
 
Here ccrit~
K{Kof f
KzKinit
 1=n
is the critical number of free
CTPsyn monomers and F xð Þ is
F xð Þ~xn 1{ Nz1ð Þx
nNzNxnNzn
1{xnð Þ2
" #
From the above equation, we can derive the relationship between
free CTPsyn monomers and total amount of CTPsyn. For a
cytoophidium of size 5 mm and CTPsyn protein of size 10 nm, we
estimated N~500. When nN&1, F xð Þ? x
n
1{xnð Þ2 for xv1.
When c%ccrit, F xð Þ?0, CTotal?c and all CTPsyn are in the form
of monomers. When c?ccrit, F rð Þ??, CTotal??. In other
words, c is kept close to ccrit when CTotal is significantly
overexpressed.
Our model can be readily generalised to include the CTPsyn in
toroidal cytoophidia by considering the circularisation of linear
cytoophidia as additional reversible biochemical reactions. Because
circular cytoophidia are in equilibrium with linear cytoophidia of
the same length and will not further increase in sizes, the inclusion
of circular cytoophidia only leads to multiplying the amount of
CTPsyn sequestered in filament by a constant. Furthermore,
including the formation of macro-cytoophidia from the nucleation
of micro-cytoophidia into our model does not change the nature of
our result either. It is worth noting that cytoophidia only becomes
visible after it is longer than a certain size. In our model the number
of filaments exponentially decreases as the size increases.
Therefore, the visible filament longer than the detection limit in a
single cell can be very small. This explains 1–3 fibres per cells
shown by our images while the majority of CTPsyn is sequestered
into filaments below the limit of detection.
In order to determine whether our model was applicable to
experimental data, we have fitted our model using the measured
concentrations of CTP in wild type and CTPsyn overexpressing
human 293T cells. We assumed that the CTP concentration is
proportional to the concentration of catalytic active form of
CTPsyn, tetramer D2, and the cytophidium is formed by
polymerization of dimers. According to our model, total
CTPsyn and CTP concentration follow the relationship:
CTotal*
CTP1=2
1{
CTP
CTPcrit
 1
2
" #2 where CTPcrit is the critical value
of CTP. We fitted the data by non-linear regression (R250.96)
(Fig. 6G).
Our model predicts that CTP concentration does not increase
linearly with total CTPsyn and reaches a plateau quickly when
CTPsyn is overexpressed. This predicted upper limit of CTP
(CTPcrit~0:29) is only 3-fold higher than the measured CTP
concentration (0.09) in wild type cells. This indicates that the level
of CTP in the cells has been significantly buffered during CTPsyn
overexpression due to cytophidium formation. This is because most
CTPsyn enters into cytoophidia when CTPsyn is overexpressed.
The amount of free CTPsyn monomers, dimers and tetramers are
kept fairly constant but can be quickly released from the filament
when CTPsyn is significantly depleted. This suggests that
cytoophidia acts as a reservoir to tightly regulate the free active
CTPsyn level to mediate cellular nucleotide homeostasis.
DISCUSSION
We demonstrate that cytoophidia assemble during periods of
cellular quiescence or low nucleotide demand as a mechanism to
inhibit CTPsyn activity in cultured cells and in vivo. Our
metabolomic data show that overexpressing CTPsyn has no overt
effect on metabolic profiles, supporting the hypothesis that the
formation of cytoophidia acts to sequester CTPsyn enzyme
activity. Therefore cytoophidium formation is a physiologically
relevant process during development and in mediating adaptive
metabolic responses (Fig. 6H).
Polymerisation as a strategy for regulation of enzymatic
activity
As the rate limiting enzyme in de novo CTP biosynthesis, CTPsyn
occupies a central regulatory role in nucleotide metabolism. It is
therefore unsurprising that it is subject to several complementary
regulatory strategies. Not only is CTPsyn regulated by multimer
assembly, end product inhibition and other allosteric regulators as
previously discussed, it is also subject to phosphorylation by
multiple kinases (Chang et al., 2007; Choi and Carman, 2007;
Kassel et al., 2010). The discovery that CTPsyn activity is also
regulated by assembly into higher-order cytoplasmic filaments
adds a further level of sophistication to this already finely
controlled metabolic pathway. It is unclear from the data
presented here what the purpose of this extra level of
enzymatic control is required for, however it is possible to
speculate that cytoophidium assembly allows for CTPsyn activity
to be rapidly up-regulated when required. The large surface area
of a filamentous aggregate such as cytoophidia would allow for
easy access by diffusible allosteric regulators in the cytoplasm,
thereby facilitating rapid disassembly and upregulation. Punctate
structures or vesicle bound enzymes may be subject to less rapid
activation by similar mechanisms as the cytoplasmic surface area
would be smaller.
Our mathematical model, and supporting data, indicate that
cellular CTP pools may increase to a maximum of around 3-fold,
regardless of the concentration of CTPsyn. We were unable to
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detect any overt cellular phenotypes arising from CTPsyn
overexpression either in cell culture or in vivo models.
Therefore, we hypothesise that up to a 3-fold increase in CTP
levels has a negligible effect on normal cellular growth and
development. This may be considered surprising, given the
propensity for tumours to overexpress CTPsyn, and the efficacy
of CTPsyn inhibitors as anti-neoplastic drugs. Further study will be
required to elucidate whether the 3-fold CTP limit is overcome
during tumourigenesis or whether these small changes are
sufficient to impact cell growth in certain pathological states.
We have focused on the assembly of CTPsyn into cytoophidia
in this study, however, it remains unclear the extent to which the
novel mechanisms for enzymatic regulation suggested here apply
to other recently identified filament forming enzymes. Screening
of yeast GFP strain collections have identified at least four novel
enzyme filaments which appear to be morphologically similar to
cytoophidia, although their functions remain elusive (Noree et al.,
2010). Moreover, it is unclear whether all filament forming
enzymes are subject to enzymatic downregulation when
assembled into cytoplasmic filaments. For example, it has long
been known that polymerisation of acetyl Co-A carboxylase
(ACC) upregulates enzymes activity, although it is unclear
whether ACC forms equivalent macro-scale cytoplasmic
structures (Beaty and Lane, 1983a; Beaty and Lane, 1983b;
Kleinschmidt et al., 1969; Olivares et al., 2011). Recently, it was
demonstrated that glutamine synthase is regulated in a similar
manner, indicating that downregulation of activity through
polymerisation may be a widespread mechanism by which
enzymes are regulated (Petrovska et al., 2014).
Role of cytoophidium formation in neurodevelopment
It was previously shown that CTPsyn is highly expressed in third
instar larval neuroblasts and exhibits a diffuse cytoplasmic
localisation (Chen et al., 2011). Here we have shown that
cytoophidia are highly prevalent in the quiescent neuroblasts of
the early larval CNS. Having shown that CTPsyn activity is likely
to be inhibited by incorporation into cytoophidia, we can now
speculate that the disassembly of cytoophidia is necessary to
synthesis critical nucleotides necessary for the transition of these
cells from quiescence to proliferation after re-entering the cell
cycle. It is not clear from these data however, whether the
dispersal of CTPsyn is regulated by cell cycle regulators acting on
CTPsyn itself (e.g. by phosphorylation) or through changes in
concentrations of allosteric regulators previously shown to effect
cytoophidium formation.
Highly regulated nucleotide metabolism is vital for the
development of most metazoan tissues due to the essential
requirement for de novo nucleotides for DNA synthesis.
However, several inborn errors of nucleotide metabolism result
in conditions with severe neurological symptoms whilst other
tissues are seemingly less affected, such as hypoxanthine–
guanine phosphoribosyl transferase (HGPRT) deficiency
(Lesch–Nyhan disease) (Lesch and Nyhan, 1964). Therefore
understanding the control of nucleotide metabolism in the
developing CNS is of particular interest for understanding the
mechanisms of hereditary pyrimidine enzymopathies.
The data presented here suggest that as well as being involved
in the co-ordination of developmental processes, the
compartmentalisation of CTPsyn into cytoophidia is involved in
mediating adaptive metabolic responses to nutrient availability in
tissue culture and in vivo. A protein localisation screen of yeast
GFP strains previously identified an unprecedented number of
proteins exhibiting cytoplasmic redistribution into punctae during
nutrient restriction (Narayanaswamy et al., 2009). This indicates
that CTPsyn is not the only protein to be regulated by spatial re-
organisation in response to extrinsic signals. Further research will
be required to determine whether cytoophidium dissociation is
required for cells to re-enter the cell cycle following nutrient
stress.
Conclusion
Although it has been demonstrated previously that CTPsyn
activity seems to be intimately linked to its polymerisation state,
it has been unclear whether cytoophidia contains catalytically
active or inactive CTPsyn. Our study suggests that CTPsyn
dimers may be the multimer subunits of cytoophidia, the
incorporation of which acts to downregulate CTPsyn enzymatic
activity. It is possible that the point mutations studied here,
predicted to lie at the interfaces between the CTPsyn monomers
have unintended effects on CTPsyn structure or monomer
interactions, therefore further structural studies will be required
in the future to confirm the presence of CTPsyn dimers within
cytoophidia. However, our data are supported by previous
observations that treatment with the CTPsyn inhibitor DON
causes a reduction in tetramer formation in E. coli (Robertson,
1995). As DON results in drastically increased cytoophidia
formation, it follows that tetramers are not incorporated into
cytoophidia during drug treatment. During the preparation of this
manuscript two groups presented similar data regarding the
regulation of CTPsyn enzymatic activity by filament formation
(Barry et al., 2014; Noree et al., 2014). Both studies broadly agree
with the assertion that CTPsyn activity is downregulated by
incorporation of monomers into cytoplasmic filaments through
polymerisation. However, some controversy exists regarding the
incorporation of multimers into the filament structure. Barry et al.
have shown that the tetramer form of CTPsyn is incorporated into
cytoplasmic filaments, whereas Noree et al. have suggested that
dimers are the constituent components. This discrepancy could be
explained by lack of conservation of filament forming properties
in the model organisms studied. Our data provides some support
for the fact that dimers are incorporated into cytoophidia. This
discrepancy may be explained by a lack of conservation between
prokaryotic and eukaryotic CTPsyn, as Barry et al. have focused
on bacteria whereas Noree et al. and this manuscript have described
yeast and metazoan models respectively. However, this explanation
is unsatisfying due to the high sequence identity and conservation of
function of CTPsyn. Further investigation into the assembly of
eukaryotic cytoophidia will be required to resolve this issue.
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